STEAP3 and benign prostatic hyperplasia: Although the expression of STEAP3 in poorly differentiated prostate cancer is lower than that in well-differentiated and moderately differentiated prostate cancer, there is no difference in STEAP3 expression between benign prostatic hyperplasia and prostate cancer (Porkka et al., 2003).